以N-(2-羟苄基)-DL-缬氨酸及4,4′-联吡啶为配体的铜(Ⅱ)配合物的合成、晶体结构及抑菌活性 |
Synthesis, Crystal Structure and Antibacterial Activity of Copper(Ⅱ) Complex Containing N-(2-hydroxybenzyl)-DL-valine and 4,4′-Bipyridine |
|
摘要: 合成了一个化合物[Cu(sval)(4,4′-bipy)](sval=N-(2-羟苄基)-DL-缬氨酸阴离子,4,4′-bipy=4,4′-联吡啶),通过元素分析、红外光谱、X-射线单晶衍射及热重分析对其进行了结构表征。晶体属单斜晶系,空间群P21/c,晶胞参数:a=1.087 23(19) nm,b=1.360 1(2) nm,c=1.359 6(2) nm,β=105.433(2)°,Z=2,V=1.938 0(6) nm3,μ=1.157 mm-1,Dc=1.511 g·cm-3,F(000)=916,R1=0.033 2,wR2=0.089 1。配合物中Cu(Ⅱ)为四配位的平面四边形配位构型,该配合物通过π-π堆积和Cu…N弱相互作用形成双核结构单元,相邻双核结构单元通过Cu…O弱相互作用形成了一个一维链状结构。初步的生物活性实验表明配合物与配体相比,配合物的抑菌活性显著提高。 |
关键词: N-(2-羟苄基)-DL-缬氨酸 4,4′-联吡啶 铜配合物 晶体结构 抑菌活性 |
基金项目: |
Abstract: A compound [Cu(sval)(4,4′-bipy)] (sval=N-(2-hydroxybenzyl)-DL-valinate, 4,4′-bipy=4,4′-bipyridine) was synthesized and characterized by elemental analysis, IR, X-ray crystal diffraction and thermogravimetric analysis. It crystallizes in monoclinic system with space group P21/c. The crystal data are: a=1.087 23(19) nm, b=1.360 1(2) nm, c=1.359 6(2) nm, β=105.433(2)°, Z=2, V=1.938 0(6) nm3, μ=1.157 mm-1, Dc=1.511 g·cm-3, F(000)=916, R1=0.033 2, wR2=0.089 1. In the title complex, neutral Cu(Ⅱ) ion is four coordinated with distorted square planar geometry. The complex formed the dimeric unit through π-π stacking and Cu…N weak interactions. Every two adjacent dimeric units are linked by Cu…O weak interactions to generate a one-dimensional chain. The preliminary biological activity tests showed that antibacterial activity of the complex was significantly improved. CCDC: 855040. |
Keywords: N-(2-hydroxybenzyl)-DL-valine 4,4′-bipyridine Cu(Ⅱ) complex crystal structure antibacterial activity |
|
摘要点击次数: 1533 |
全文下载次数: 2214 |
胡久荣,闫卫红,郑大贵,叶红德,饶 敏.以N-(2-羟苄基)-DL-缬氨酸及4,4′-联吡啶为配体的铜(Ⅱ)配合物的合成、晶体结构及抑菌活性[J].无机化学学报,2012,28(3):531-535. |
查看全文 查看/发表评论 下载PDF阅读器 |
Support information: |
|
|
|